BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31919764)

  • 1. A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report.
    Tanaka T; Arigami T; Uenosono Y; Yanagita S; Matsushita D; Okubo K; Kijima T; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Ishigami S; Natsugoe S
    Surg Case Rep; 2020 Jan; 6(1):13. PubMed ID: 31919764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report.
    Kubo N; Yoshizawa J; Hanaoka T
    BMC Cancer; 2018 Jun; 18(1):627. PubMed ID: 29866101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of HER2-Positive Siewert Type I Adenocarcinoma of the Esophagogastric Junction Treated via Neoadjuvant Chemotherapy Followed by Radical Resection].
    Nakajima T; Sato T; Kano K; Maezawa Y; Segami K; Fujikawa H; Ikeda K; Yamada T; Ogata T; Cho H; Yoshikawa T
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1240-1242. PubMed ID: 27760947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
    Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Long-Term Survival in a Patient with Lung Metastasis of Gastric Cancer Treated Using Curative Surgery].
    Namikawa T; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kumon T; Nagata Y; Kobayashi M; Hanazaki K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1827-1829. PubMed ID: 30692367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Successful Multidisciplinary Therapy for Advanced Esophagogastric Junction Cancer with Multiple Lymph Node Metastase].
    Murakami K; Tamura S; Takeno A; Ishida T; Kuwahara R; Akiyama Y; Sakamoto T; Inatome J; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Egawa C; Takeda Y; Kato T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2010-2012. PubMed ID: 28133205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Recurrent Esophagogastric Junction Cancer Responding to Trastuzumab].
    Kobayashi Y; Hirao M; Yamamoto K; Nishikawa K; Maeda S; Uemura M; Miyake M; Hama N; Miyamoto A; Miyazaki M; Ikeda M; Nakamori S; Sekimoto M; Mori K; Mano M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2181-2183. PubMed ID: 28133262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of HER2-positive esophagogastric junction cancer treated by using a neoadjuvant chemotherapy regimen consisting of trastuzumab].
    Kanaya N; Arata T; Tanakaya K; Yamasaki R; Aoki H; Takeuchi H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2285-6. PubMed ID: 25731497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced esophagogastric junction cancer responding to pre-operative combination chemotherapy of docetaxel, cisplatin, S-1, and trastuzumab].
    Haruki S; Takiguchi N; Arita K; Usui S; Ito K; Matsumoto A; Hiranuma S; Bhunachet E
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1089-92. PubMed ID: 23986058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
    Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
    Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical case of lymph node recurrence after the resection of esophagogastric junction cancer treated by chemoradiation therapy].
    Oohinata R; Iwasaki Y; Oohashi M; Iwanaga T; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2378-80. PubMed ID: 23268083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Esophagogastric Junction Adenocarcinoma with Multiple Esophageal Intramural Metastases].
    Akamaru Y; Wada N; Wada R; Munakata K; Takiuchi D; Morimoto O; Ota H; Shibata K; Ohashi H
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2126-2128. PubMed ID: 30692306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.
    Hosoda K; Yamashita K; Katada N; Watanabe M
    Gen Thorac Cardiovasc Surg; 2015 Oct; 63(10):549-56. PubMed ID: 26232357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case showing a complete response by weekly paclitaxel associated with severe empyema and mediastinal abscess caused by reduction of a recurrent lung metastatic tumor originating from adenocarcinoma of the esophagogastric junction after primary operation].
    Kimura A; Hiramatsu K; Sakuragawa T; Ito T; Otsuji H; Tsuchiya T; Hara T; Maeda T; Tanaka H; Machiki Y; Hosoya J; Kojima T; Kato K
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):303-5. PubMed ID: 20154490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
    Lee IS; Ahn JY; Yook JH; Kim BS
    World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
    Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
    Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced esophagogastric junction cancer with brain, bone and gastric intramural metastases responding to combined modality therapy.
    Takagi T; Kobayashi S; Sekimura A; Komaya K; Yamauchi Y; Hori A
    J Rural Med; 2021 Jul; 16(3):179-183. PubMed ID: 34239632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.